Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02047396 · ClinicalTrials.gov registry record
Ventricular Remodeling and Heart Failure After Myocardial Infarction: A Community Study
A clinical trial of Heart Failure and Myocardial Infarction, sponsored by Mayo Clinic.
- Active
- Registry status
- 1,599
- Enrollment target
- 1
- Study location
NCT02047396 is a study of Heart Failure and Myocardial Infarction that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 1,599 participants, below the 2,045-participant average among 397 other Heart Failure trials with a reported enrollment target (22% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02047396, a study of Heart Failure and Myocardial Infarction, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- 1,599 participants
- Enrollment target
- 1
- Study location
Study Summary
To comprehensively characterize Left Ventricular (LV) remodeling after Myocardial Infarction (MI) in the community, study the association between patterns of remodeling and biological pathways and examine the association between the predictors of remodeling and heart failure after Myocardial Infarction.
Conditions Studied
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,599 participants |
| Start Date | 2014-01 |
| Est. Completion | 2030-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02047396
The ClinicalTrials.gov registry entry for NCT02047396 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,599 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,045-participant average among 397 other Heart Failure trials with a reported enrollment target (22% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 0 interventions.
NCT02047396 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT02047396 about?
NCT02047396 is a clinical study titled "Ventricular Remodeling and Heart Failure After Myocardial Infarction: A Community Study". To comprehensively characterize Left Ventricular (LV) remodeling after Myocardial Infarction (MI) in the community, study the association between patterns of remodeling and biological pathways and examine the association between the predictors of remodeling and heart failure after Myocardial Infarct...
What is the current status of trial NCT02047396?
This trial is currently active not recruiting. The enrollment target is 1,599 participants. The study started on 2014-01. Estimated completion is 2030-01.
What conditions does trial NCT02047396 study?
This clinical trial studies the following conditions: Heart Failure, Myocardial Infarction.
Who is sponsoring clinical trial NCT02047396?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02047396 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.